The present study demonstrated that SIRT1 <i>rs12778366</i> is associated with pituitary adenoma development while STAT3 <i>rs744166</i> is associated with PA invasiveness, hormonal activity and recurrence.
However, no more statistical differences were found between STAT3 promoter methylation, mRNA expression and patient clinical characteristics or PA invasiveness or recurrence.